Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Integrating Patient-Centred Research in the Canadian Cancer Trials Group.
Curr Oncol. 2021 Jan 21;28(1):630-639. doi: 10.3390/curroncol28010062.
Curr Oncol. 2021.
PMID: 33494312
Free PMC article.
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Moku P, Shepherd L, Ali SM, Leitzel K, Parulekar WR, Zhu L, Virk S, Nomikos D, Aparicio S, Gelmon K, Drabick J, Cream L, Halstead ES, Umstead TM, Mckeone D, Polimera H, Maddukuri A, Ali A, Nagabhairu V, Poulose J, Pancholy N, Spiegel H, Chen BE, Lipton A.
Moku P, et al. Among authors: nomikos d.
Cancer. 2020 Nov 15;126(22):4859-4866. doi: 10.1002/cncr.33149. Epub 2020 Sep 10.
Cancer. 2020.
PMID: 32910476
Free article.
Item in Clipboard
Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval.
Goffin J, Baral S, Tu D, Nomikos D, Seymour L.
Goffin J, et al. Among authors: nomikos d.
Clin Cancer Res. 2005 Aug 15;11(16):5928-34. doi: 10.1158/1078-0432.CCR-05-0130.
Clin Cancer Res. 2005.
PMID: 16115935
Review.
Item in Clipboard
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.
Gelmon KA, Boyle FM, Kaufman B, Huntsman DG, Manikhas A, Di Leo A, Martin M, Schwartzberg LS, Lemieux J, Aparicio S, Shepherd LE, Dent S, Ellard SL, Tonkin K, Pritchard KI, Whelan TJ, Nomikos D, Nusch A, Coleman RE, Mukai H, Tjulandin S, Khasanov R, Rizel S, Connor AP, Santillana SL, Chapman JA, Parulekar WR.
Gelmon KA, et al. Among authors: nomikos d.
J Clin Oncol. 2015 May 10;33(14):1574-83. doi: 10.1200/JCO.2014.56.9590. Epub 2015 Mar 16.
J Clin Oncol. 2015.
PMID: 25779558
Clinical Trial.
Item in Clipboard
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Ho D, Huang J, Chapman JW, Leitzel K, Ali SM, Shepherd L, Parulekar WR, Ellis CE, Crescnzo RJ, Zhu L, Virk S, Nomikos D, Aparicio S, Gelmon KA, Carney WP, Lipton A.
Ho D, et al. Among authors: nomikos d.
Breast Cancer Res Treat. 2017 Aug;164(3):571-580. doi: 10.1007/s10549-017-4273-x. Epub 2017 May 8.
Breast Cancer Res Treat. 2017.
PMID: 28484925
Clinical Trial.
Item in Clipboard
Cite
Cite